This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (66)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Donald F. Klein, MD; Bernard Rosen, MS

Arch Gen Psychiatry. 1973;29(4):480-485.

Abstract
This study examined the relationship between premorbid asocial adjustment and response to phenothiazine treatment. The sample consisted of 88 hospitalized schizophrenic patients who were randomly assigned to either placebo or chlorpromazine and treated on a fixed-dosage increment schedule, under double-blind conditions for six weeks.

Results support the hypothesis that response to phenothiazine treatment differs between asocial and nonasocial patients. Chlorpromazine had consistently positive effects in reducing psychopathology among nonasocial patients. However, among asocial patients chlorpromazine showed both positive and negative effects.

Chlorpromazine's negative effects were significantly greater among asocial as compared to nonasocial patients, while its positive effects were significantly greater among nonasocial than asocial patients.

Author Affiliations
Glen Oaks, NY

From the Research Department, Hillside Division, Long Island Jewish-Hillside Medical Center, Glen Oaks, NY.

Footnotes
Accepted for publication April 30, 1973.

Reprint requests to Research Department, Hillside Division, Long Island Jewish-Hillside Medical Center, Glen Oaks, NY 11004 (Dr. Klein).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Minimal-medication approaches to treating schizophrenia
Calton and Spandler
Adv. Psychiatr. Treat. 2009;15:209-217.
ABSTRACT | FULL TEXT  

A Longitudinal Study of Symptom Dimensions in Schizophrenia: Prediction and Patterns of Change
Arndt et al.
Arch Gen Psychiatry 1995;52:352-360.
ABSTRACT  

The Chestnut Lodge Follow-up Study: I. Follow-up Methodology and Study Sample
McGlashan
Arch Gen Psychiatry 1984;41:573-585.
ABSTRACT  

Predicting Drug-Free Improvement in Schizophrenic Psychosis
Marder et al.
Arch Gen Psychiatry 1979;36:1080-1085.
ABSTRACT  

'Akinetic Depression' in Schizophrenia
Van Putten and May
Arch Gen Psychiatry 1978;35:1101-1107.
ABSTRACT  

Phenothiazine Effects on Psychological and Psychophysiological Dysfunction in Chronic Schizophrenics
Spohn et al.
Arch Gen Psychiatry 1977;34:633-644.
ABSTRACT  

Short vs Long Hospitalization: A Prospective Controlled Study: VI. Two-Year Follow-up Results for Schizophrenics
Hargreaves et al.
Arch Gen Psychiatry 1977;34:305-311.
ABSTRACT  

Prediction of Relapse in Schizophrenic Outpatients Treated by Drug and Sociotherapy
Goldberg et al.
Arch Gen Psychiatry 1977;34:171-184.
ABSTRACT  

Neurologic Soft Signs in Schizophrenia and Character Disorders: Organicity in Schizophrenia With Premorbid Asociality and Emotionally Unstable Character Disorders
Quitkin et al.
Arch Gen Psychiatry 1976;33:845-853.
ABSTRACT  

Very High Dosage vs Standard Dosage Fluphenazine in Schizophrenia: Frederic Quitkin, MD; Arthur Rifkin, MD; Donald F. Klein, MD
Quitkin et al.
Arch Gen Psychiatry 1975;32:1276-1281.
ABSTRACT  

Amitriptyline-Perphenazine Interaction in Ambulatory Schizophrenic Patients: A Controlled Study of Drug Interaction
Chouinard et al.
Arch Gen Psychiatry 1975;32:1295-1307.
ABSTRACT